CJC-1295/Ipamorelin
aka CJC-1295 (no DAC) + Ipamorelin blend
Growth Hormone Secretagogues
Mechanism
A grey-market pre-mixed blend of CJC-1295 (no DAC / Modified GRF 1-29), a GHRH analog, and Ipamorelin, a selective ghrelin-receptor agonist. The blend itself is NOT clinically validated — no controlled human trial has tested this specific combination. The pharmacological rationale (GHRH + GHRP synergy for pulsatile GH amplification) is inferred from studies of other GHRH/GHRP pairs.
Identification
Vendors selling CJC-1295/Ipamorelin
No vendor listings on file yet.
Research
No citations on file yet.